Pure Global AI
DIGEMAPS · structured requirements

🇩🇴 Dominican Republic medical device regulatory data

Explore the medical device requirements currently available for Dominican Republic, organized by topic and linked to official sources.

32 facts25 dimensions19 official sourceslatest verification 2026-09-16

Advertising, claims & promotion

Which claims, audiences, channels, approvals, and restrictions apply?

Compare countries

Advertising of sanitary products requires prior authorisation and is regulated by Resolución 000033-15

advertising.prior-authorisation-and-notification
Fact-level verified
Statement

Advertising and promotion of medicines, cosmetics, sanitary products and personal and household hygiene products in written, radio, television and social-media channels addressed to the general public requires authorisation or notification from DIGEMAPS, under the reglamento brought into force by Resolución 000033-15 which regulates advertising and promotion of those products. The request is filed on form DIGEMAPS-RS-LI-058 with the advertising material in printed and electronic form and one fee payment per brand or product; the published cost is RD$1,000.00 for authorisations and no cost for a publicity notification, with a response time of 25 business days.

Source Approval

none

Target Jurisdiction Id

dominican-republic

Edge Type

No Reliance Route

Market Access Strength

none

Regulatory Layer

Market Oversight

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • Evaluation is documentary and then on site.
  • Ley 42-01 Art. 119 forbids attributing any therapeutic action to cosmetics and personal-hygiene products in the name, indications, instructions or advertising.

Spanish. English of the base legal: 'Resolucion 000033-15, que pone en vigencia el reglamento que regula la publicidad y promoción de medicamentos, cosméticos, productos sanitarios, de higiene personal y del hogar.' The service description covers authorisation for advertising and promotions of over-the-counter medicines, cosmetics, sanitary products and personal and household hygiene products in written, radio, television and social-media channels directed at the general public.

Approval validity & renewal

What expires, what is retained periodically, and when must renewal start?

Compare countries

Sanitary authorisation is temporary and must be revalidated

renewal.authorisation-temporal-and-revalidation-duty
Fact-level verified
Statement

Under the Ley General de Salud the authorisation for medicines and other sanitary products is temporary; once its term expires it must be revalidated in the form and within the period set by regulation, and the holder must notify its intention to keep the products on the market so that the authorisation does not lapse.

Source Approval

none

Target Jurisdiction Id

dominican-republic

Edge Type

No Reliance Route

Market Access Strength

none

Regulatory Layer

Market Oversight

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • The law does not state the numeric term of validity for sanitary products; the operative renewal windows are set by Decreto 45-23 (see the automatic-renewal fact).
  • The same article allows suspension or revocation for grave public-health cause or quality deficiencies.

Spanish. English: 'The authorisation for medicines and other sanitary products shall be temporary. Once its term has expired it must be revalidated within the period and in the form laid down in the regulation issued for the purpose. The holder must notify its intention to keep the products on the market so that the authorisation does not prescribe, and the authorisation shall be renewed upon compliance with the requirements established by SESPAS.' The numeric validity term for sanitary products could not be evidenced from a primary instrument.

Renewal is automatic on payment while the registration is in force; applications lodge in the last three months

renewal.automatic-renewal-and-lodgement-window
Fact-level verified
Statement

Renewal of the sanitary registration of foods, medicines, sanitary products, cosmetics and hygiene products is automatic provided the renewal service fee has been paid and the registration to be renewed is in force. The holder must file the renewal application within the three months before expiry; if the expiry date passes without an application the registration is cancelled with no right to an extension. Applications are filed on the corresponding form with proof of payment, a current GMP certificate where applicable and a current distributor certificate where applicable.

Source Approval

none

Target Jurisdiction Id

dominican-republic

Edge Type

No Reliance Route

Market Access Strength

none

Regulatory Layer

Market Oversight

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • Where the registration has changed in any way, the modification application must be filed at the same time as the renewal with both fees.
  • If DIGEMAPS finds a discrepancy or modification against the automatically renewed registration, the holder is notified and must submit the modification procedure within 15 calendar days, without prejudice to statutory sanctions.

Effective from 2023-02-14

Spanish. English: 'The renewal of the sanitary registrations of foods, medicines, sanitary products, cosmetics, personal and household hygiene shall be automatic provided that: a) the renewal service fee has been paid, whether electronically or physically; b) the sanitary registration of the product to be renewed is in force.' and 'The user must submit the renewal application within the 3 months prior to its expiry. Once the expiry date arrives without the renewal application having been submitted, the sanitary registration shall be cancelled, with no right to an extension.'

Authority & regime

Which authority and binding regime govern this product, task, and date?

Compare countries

DIGEMAPS is the competent authority for medical devices, created by Decreto 82-15 under the Ministry of Public Health

authority.digemaps-under-msp
Fact-level verified
Statement

The Dirección General de Medicamentos, Alimentos y Productos Sanitarios (DIGEMAPS) is the regulatory authority for medicines, food and sanitary products (including medical devices), created by Decreto núm. 82-15 of 6 April 2015 under the dependency of the Ministerio de Salud Pública y Asistencia Social, and it also amended article 81 of the medicines regulation Decreto 246-06. Registration is handled by DIGEMAPS' Dirección de Registro Sanitario and post-market matters by its Dirección de Vigilancia Sanitaria; service requests are received through the MSP Ventanilla Única de Servicios.

Source Approval

none

Target Jurisdiction Id

dominican-republic

Edge Type

No Reliance Route

Market Access Strength

none

Regulatory Layer

Market Oversight

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • The registry's display label 'DIGEMAPS' is the authority's own acronym and is correct; the full name is Dirección General de Medicamentos, Alimentos y Productos Sanitarios.

Spanish. English: 'Decreto No. 82-15, which creates the Dirección General de Medicamentos, Alimentos y Productos Sanitarios (DIGEMAPS), under the dependency of the Ministry of Health and Social Assistance, of 6 April 2015.' The DIGEMAPS registration service page names 'DIGEMAPS – Dirección de Registro Sanitario' as the offering department and the advertising and distributor establishment pages name 'DIGEMAPS – Dirección de Vigilancia Sanitaria'.

Change control

Does the event require internal documentation, notice, prior approval, transfer, or a new application?

Compare countries

Modifications are filed with the renewal; a modification in the last six months renews the registration

change.modification-filed-with-renewal-and-six-month-window
Fact-level verified
Statement

Where the registration has undergone changes of any nature the holder must file the modification application at the same time as the renewal and pay the fees for that transaction; where a modification is filed within the six months before expiry, issuance of the modification carries the automatic renewal of the registration, with the renewal fee paid at the time of filing. DIGEMAPS operates separate modification transactions for a change of representative, title holder, company name, excipients, shelf life, trade mark, inclusion of a co-distributor, primary packaging, manufacturing process and control method, and packaging/labels/insert updates for sanitary products.

Source Approval

none

Target Jurisdiction Id

dominican-republic

Edge Type

No Reliance Route

Market Access Strength

none

Regulatory Layer

Market Oversight

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • Modifications to a manufacturer's installations, substantial changes to the technical data sheet, packaging materials, information system, manufacturing and control process, and non-bioavailability-affecting excipient changes are eligible for the simplified procedure under Resolución No. 000004 PRIMERO.
  • A modification application uses form DGDF-RP-FO-004.

Effective from 2023-02-14

Spanish. English: 'PÁRRAFO I. If the sanitary registration has undergone changes of any nature, the user must submit the modification application at the same time as the renewal, paying the fees corresponding to that transaction.' and 'ARTÍCULO 5. In those cases where a modification is submitted within the 6 months prior to the expiry of the sanitary registration, its issuance shall entail the automatic renewal.'

Classification rules

What local class follows from which rules and decisive product facts?

Compare countries

Being 'classified as low risk by DIGEMAPS' is one of three gateways to the simplified registration procedure (Res. 000004-16, SEGUNDO num. 3)

classification.low-risk-classification-by-digemaps-opens-simplified-procedure
Fact-level verified

Resolución 000004-16 lists three alternative criteria for a new registration or renewal to use the simplified procedure: (1) imported products previously authorised by a WHO stringent authority or a PAHO/Red PARF regional reference authority, evidenced by that authority's free-sale and GMP certificates; (2) products of national manufacturers meeting the national GMP norms and the Red PARF harmonised GMP inspection guide; (3) products that DIGEMAPS has classified as low risk. Products with quality failures found in post-marketing monitoring or serious safety reports are excluded.

Conditions
  • The resolution is drafted for medicines (it invokes the Decreto 246-06 Reglamento sobre Medicamentos) but is cited by DIGEMAPS as legal basis for the sanitary-product registration service.
  • No published DIGEMAPS criteria or list defining which sanitary products are 'low risk' was located.
  • Applied from 1 April 2016 (SEXTO).

Effective from 2016-04-01

English gist: a DIGEMAPS low-risk classification is a stand-alone route into the simplified procedure; products with post-market quality failures or serious safety reports are excluded. Transcribed from the scanned resolution (OCR checked against the page).

Clinical investigation & performance

Which clinical or IVD performance evidence or study is required and accepted?

Compare countries

Prior CONABIOS approval and supervision of clinical and biomedical research

clinical-investigation.prior-conabios-approval-and-supervision
Fact-level verified
Statement

Every clinical and biomedical investigation carried out in Dominican territory must obtain CONABIOS's prior approval and be supervised by it, the protocol having to respect the life, integrity and dignity of participants, obtain informed consent under the bioethics rules in force, guarantee participant confidentiality, present no unjustified risk with benefits proportional to the risks, and contain all requirements of CONABIOS's Manual de Normas y Procedimientos Operativos. CONABIOS monitors each approved investigation continuously and may revoke the authorisation or suspend the investigation provisionally according to the gravity of the breach; responsible investigators must send it the reports and documents it requires at the periods it sets.

Article

ARTICULO 10 y Párrafos I-III

Conditions
  • The CONABIOS Reglamento Interno adds a lead time: the protocol must be submitted for CONABIOS evaluation and approval 30 days before the planned start date, and CONABIOS may suspend the investigation temporarily or definitively if it finds irregularity, grave faults or danger to the health and wellbeing of participants.
  • Ethics committees must be accredited by CONABIOS (Decreto 351-25 art. 10, Párrafo III).
  • CONABIOS must observe the guarantees of administrative due process and the applicable provisions of Ley núm. 107-13 when exercising suspension powers (Decreto 351-25 art. 10, Párrafo V).
  • Decreto 351-25 art. 10 applies to clinical and biomedical investigation generally, without a device-specific rule; the instrument predates and governs the CONABIOS Reglamento Interno, which was ordered by MSP Resolución No. 000038 of 21 October 2020.

Spanish. Decreto núm. 351-25 is signed 'LUIS ABINADER, PRESIDENTE DE LA REPÚBLICA DOMINICANA' and its date line reads 'Dado en la ciudad de Santo Domingo de Guzmán, Distrito Nacional, capital de la República, a ... del año dos mil veinticinco'; the day and month in that line did not survive the PDF text layer, so no effective date is asserted here. Párrafo I, verbatim: 'El CONABIOS deberá dar monitoreo continuo a cada una de las investigaciones aprobadas por el Consejo, teniendo la potestad de revocar la autorización o suspender provisionalmente la investigación, según la gravedad de la violación a los principios y normas bioéticas, los reglamentos establecidos y los derechos fundamentales de los participantes.' — 'CONABIOS shall continuously monitor each investigation it approves, with the power to revoke the authorisation or provisionally suspend the investigation according to the gravity of the breach of bioethical principles and rules, the established regulations and the fundamental rights of participants.' The supporting instrument, CONABIOS Reglamento Interno art. 5 Párrafo, verbatim: 'Toda investigación que se realice en seres humanos, su protocolo deberá someterse a un proceso de evaluación y aprobación por el Consejo Nacional de Bioética en Salud (CONABIOS), previo a su implementación, con 30 días de anticipación a la fecha prevista para su inicio y a la supervisión por este Consejo, durante su fase de ejecución el cual dará seguimiento al cumplimiento del rigor científico y a los principios bioéticos que la sustentan, teniendo la facultad y responsabilidad de suspenderla temporal o definitivamente si se comprueba irregularidad, faltas graves y / o peligro de riegos de salud y del bienestar de los sujetos participantes.' — 'Every investigation carried out in human beings must have its protocol submitted for evaluation and approval by CONABIOS prior to its implementation, 30 days before the planned start date, and be supervised by the Council during its execution phase, which will follow up compliance with scientific rigour and the bioethical principles underpinning it, having the power and responsibility to suspend it temporarily or definitively if irregularity, grave faults and/or danger to the health and wellbeing of the participating subjects is established.' Art. 5 also defines CONABIOS as 'la autoridad reguladora que garantiza la calidad científica y el cumplimiento de los principios éticos de las investigaciones en las que participan sujetos humanos en la República Dominicana'.

Device definition & scope

Is the product a device, IVD, accessory, software, or borderline product locally?

Compare countries

Product categories the health law subjects to sanitary control

scope.device-categories-under-health-law
Fact-level verified
Statement

Article 109 of the Ley General de Salud assigns the Ministry of Public Health, through the institutions created for the purpose, sanitary control of medical equipment, prostheses, orthoses, functional aids, diagnostic agents, dental-use supplies, surgical and healing materials and hygiene products — covering the process, use, maintenance, import, export and final disposal of those goods. The law's glossary defines prostheses, orthoses and functional aids as devices intended to substitute for or complement a function, organ or tissue of the human body.

Source Approval

none

Target Jurisdiction Id

dominican-republic

Edge Type

No Reliance Route

Market Access Strength

none

Regulatory Layer

Market Oversight

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • Article 109 is drafted as a list of product families rather than as a single statutory definition of 'medical device'.
  • In vitro diagnostic agents fall within 'agentes de diagnóstico'.

Spanish, quoted verbatim from the law as published by DIGEMAPS (the PDF retains the original OCR spacing of the published text, e.g. 'USO', 'irnportacion'). English: 'Sanitary control of the process, the use, the maintenance, the import, the export and the final disposal of medical equipment, prostheses, orthoses, functional aids, diagnostic agents, dental-use supplies, surgical and healing materials and hygiene products.' The glossary entry reads: 'Prótesis, ortesis y ayudas funcionales: Los dispositivos destinados a sustituir o complementar una función, un órgano o un tejido del cuerpo humano.'

Dossier requirements

Which evidence, local deltas, formats, and signatures are required?

Compare countries

Contents of the registration dossier for an imported medical device

dossier.imported-device-registration-file
Fact-level verified
Statement

The dossier for an imported sanitary product comprises: the registration application form; the representative establishment's current registration certificate; the notarised/apostilled power of representation; the manufacturing or packaging contract where applicable; a current ONAPI trade-mark certificate where applicable; the origin-country free-sale certificate and the manufacturer's GMP or quality-system certificate, legalised or apostilled; the manufacturing certification in maquila cases; proof of tax payment; a product description listing the main parts and, where applicable, qualitative-quantitative composition, specifications, operation and descriptive information; plans or schematics of the product (for medical devices); for device families, a summary description of the family and the list of codes or products composing it; technical studies and analytical checks with a summary of design tests and specifications; the manufacturing method with flow chart, process description and controls; quality-control methods signed by the quality-control officer; an original certificate of analysis of the finished product covering physico-chemical, microbiological, pyrogen and sterility testing as applicable, with lot number, manufacture and expiry dates and acceptance ranges, matched to the deposited samples and signed by the quality-control officer; two original samples of the finished product with at least one year of validity; the disposal method where applicable; the professional-use information including indications, warnings, precautions, contraindications and the product's risk level; the proposed package insert or instructions; proposed primary and secondary packaging; and the official technical sheet (DGDF-RP-FO-005) and professional information sheet (DGDF-RP-FO-007).

Source Approval

none

Target Jurisdiction Id

dominican-republic

Edge Type

No Reliance Route

Market Access Strength

none

Regulatory Layer

Premarket Review

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • Two original finished-product samples must be deposited with at least one year of remaining validity.
  • The professional-use information must state the product's risk level.
  • The same page lists the requirements for renewal separately.

Spanish. Excerpt gives the two sample-related and risk-declaration requirements verbatim; the remainder of the list is summarised in the statement. English of the excerpt: 'Two (2) original samples of the finished product, with at least 1 year of validity' and 'Professional use information for the product, including uses and indications, warnings, precautions and contraindications and the risk level of the product.'

Economic-operator roles

Which manufacturer, representative, holder, applicant, importer, and distributor roles apply?

Compare countries

A locally registered pharmaceutical establishment must act as representative

operator.local-pharmaceutical-establishment-representative
Fact-level verified
Statement

The foreign title holder must grant a power of representation to a pharmaceutical establishment established as representative in the Dominican Republic, duly notarised and certified before the Procuraduría for national applicants or legalised/apostilled for imported products; the applicant must supply a current copy of the sanitary-registration certificate of the requesting/representing pharmaceutical establishment, laboratory or distributor. For imported products, Ley 42-01 requires the application to be endorsed by the pharmacist in charge of the distributor.

Source Approval

none

Target Jurisdiction Id

dominican-republic

Edge Type

No Reliance Route

Market Access Strength

none

Regulatory Layer

Premarket Review

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • The representative must itself hold a current establishment sanitary registration.
  • A manufacturing/packaging contract between the manufacturer and the title holder is also required where applicable, with the same authentication.
  • There is no provision for a foreign applicant to hold a Dominican registration directly.

Spanish. English: 'Power of representation from the title-holder company in favour of the pharmaceutical establishment representing it in the Dominican Republic, duly notarised and certified before the Procuraduría (national) / legalised or apostilled (imported).' Ley 42-01 Art. 115 Párrafo IV adds that imported products must be endorsed by the pharmacist in charge (farmacéutico regente) of the distributor.

Establishment, import & distribution

Which establishment licences, importer permissions, and distribution controls apply?

Compare countries

Distributors must be habilitated and run by a licensed pharmaceutical technical director

establishment.distributor-habilitation-and-technical-director
Fact-level verified
Statement

Opening, relocating or renewing a distributor requires an evaluation and inspection by DIGEMAPS' Dirección de Vigilancia Sanitaria leading to a habilitation certificate; the file must be signed by the owner or legal representative and by a technical director who is a qualified pharmaceutical professional, whose academic title and exequatur certification must be filed, together with the company's commercial registry, tax registration, title deed or notarised lease, articles of association and premises plans and photographs.

Source Approval

none

Target Jurisdiction Id

dominican-republic

Edge Type

No Reliance Route

Market Access Strength

none

Regulatory Layer

Market Oversight

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • The legal basis cited by the service is Ley 42-01, Decreto 246-06 and the 2012 'Normas particulares para la habilitación de los establecimientos farmacéuticos'.
  • DIGEMAPS also operates separate services for logistic warehouses and for GMP inspection of laboratories of pharmaceutical products and sanitary products.

Spanish. English: 'Copy of the academic title of the Technical Director (Pharmaceutical Professional), as established by Ley 42-01 (Art. 103) and Decreto 246-06 (Arts. 125, 129).' The service description reads: 'The service consists of the evaluation and inspection to grant a habilitation or relocation certificate.'

Fees

What regulator fee applies to this class, route, event, and date?

Compare countries

Fee for the simplified registration procedure — sanitary products

fees.simplified-procedure-sanitary-products
Fact-level verified
Statement

The MSP publishes the cost of the simplified registration procedure for the 'Productos Sanitarios' modality as RD$18,000.00 for a new registration and RD$18,000.00 for a renewal, payable by deposit or certified cheque to the Tesorería Nacional account at Banco de Reservas.

Source Approval

none

Target Jurisdiction Id

dominican-republic

Edge Type

No Reliance Route

Market Access Strength

none

Regulatory Layer

Premarket Review

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • The DIGEMAPS registration service page for sanitary products publishes 'RD$ 9,000 Para Medicamento' for the ordinary registration transaction, a figure the page itself qualifies as being for medicines; the two pages are not consistent for sanitary products and the MSP service listing is the one that names the 'Productos Sanitarios' line explicitly.
  • Fees are set by Resolución 000020 and Resolución 000016 as cited in the base legal of both pages.

Spanish. The cost table reads: 'Nuevo: -Medicamentos: RD$42,000.00. -Cosméticos, Productos de Higiene Personal y del Hogar: RD$9,000.00. -Productos Sanitarios: RD$18,000.00. -Alimentos y Bebidas: RD$4,000.00.' with the same four lines repeated under 'Renovación'. Fee amounts are due for re-verification after 12 months under the review policy.

Label, IFU & language

Which label and IFU elements, languages, symbols, and translation controls apply?

Compare countries

Documents in a language other than Spanish must be translated by a judicial interpreter

label.spanish-language-translation-and-artwork
Fact-level verified
Statement

Ley 42-01 Art. 112 requires the legends and texts of the labels of the products covered by Libro Cuarto (which includes the Art. 109(b) device families) to be written in Spanish, and imported products must carry a counter-label in Spanish with all the required data. Labels, package inserts, leaflets, blisters and any other packaging material must be filed with the renewal as they are actually marketed, and where documents are in a language other than Spanish they must be translated by a judicial interpreter. The registration file requires a proposed insert or instruction leaflet and proposed primary and secondary packaging.

Source Approval

none

Target Jurisdiction Id

dominican-republic

Edge Type

No Reliance Route

Market Access Strength

none

Regulatory Layer

Premarket Review

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • The judicial-interpreter rule is a translation requirement on filed documents; the labelling-language mandate itself is statutory (Ley 42-01 Art. 112 and its Párrafo).
  • Artwork changes are a separate modification transaction (Actualización de Empaque, Etiquetas e Inserto).

Spanish. English: 'Instructions for use, labels, markings, blisters and any other type of original packaging material as the product is being marketed in the market.' and 'Where the documents are in a language other than Spanish they must be translated by a judicial interpreter.'

Manufacturer PMS

Which PMS plan, report, PMCF or PMPF, trend, and lifecycle-update duties apply?

Compare countries

Holder's adverse-effect reporting duty and renewal pharmacovigilance filing

pms.holder-adverse-effect-reporting-and-renewal-pharmacovigilance
Fact-level verified
Statement

Sanitary authorisations for medicines and other sanitary products are temporary: the holder must notify its intention to keep the products on the market so the authorisation does not lapse, and renew it on compliance with the authority's requirements. Importers, manufacturers and health professionals are obliged to communicate adverse effects caused by medicines and other sanitary products when a danger to life or health may derive from them, or when the therapeutic effect proves invalid or does not produce the expected effects. At renewal, DIGEMAPS requires the applicant to file pharmacovigilance information covering every suspected serious adverse reaction of which it is aware, both in the country and abroad, and to state expressly and demonstrably where it considers there is no notable incidence.

Article

Art. 116, primer párrafo y Párrafo I

Conditions
  • Art. 116 Párrafo I is addressed to 'los importadores, fabricantes y profesionales de la salud' and names 'medicamentos y otros productos sanitarios', so the reporting duty reaches medical devices and their importers, not only medicines.
  • The reporting duty is tied to the authority's power to suspend or revoke the authorisation for grave public-health cause or product-quality deficiencies.
  • The renewal filing is published on DIGEMAPS's Renovación de Registro Sanitario de Productos Sanitarios service page (supporting source), which also requires that documents in a language other than Spanish be translated by a judicial interpreter.
  • No periodic PSUR or device post-market-report cadence, and no device-specific PMS plan or periodic safety report deadline, was found.

Spanish; the excerpt reproduces the OCR artefacts of the source PDF ('10s', 'autorizacion', 'terapeutico'). Art. 116, first paragraph, verbatim: 'La autorizacion de 10s medicamentos y demis productos sanitarios sera temporal. Agotada su vigencia, debera revalidarse en el plazo y la forma consagrada en la reglamentacion dictada a1 efecto. El titular debera notificar su intencion de mantener 10s productos en el mercado para que no prescriba la autorizacion, y se renovara la autorizacion previo cumplimiento de 10s requisitos consagrados por SESPAS.' — 'The authorisation of medicines and other sanitary products is temporary. Once its term expires it must be revalidated within the period and in the form laid down in the regulation issued for that purpose. The holder must notify its intention to keep the products on the market so that the authorisation does not lapse, and the authorisation shall be renewed on compliance with the requirements established by SESPAS.' The supporting source, DIGEMAPS renewal service page, 'Requisitos o requerimientos', verbatim: 'Información sobre fármaco-vigilancia del producto que incluya toda sospecha de reacción adversa grave de la que se tuviera sospecha tanto en el ámbito del país como en el extranjero, en caso de que no sea necesario este requerimiento por estimar que no hay ninguna incidencia destacable lo deberán explicitar fehacientemente en la documentación. Dicha información o resumen de esta debe ser depositada físicamente además de la versión electrónica (cuando aplique).' — 'Pharmacovigilance information on the product covering every suspected serious adverse reaction of which there is suspicion, both in the country and abroad; where this requirement is not necessary because it is considered that there is no notable incidence, this must be stated expressly and demonstrably in the documentation. That information or a summary of it must be filed physically in addition to the electronic version (where applicable).'

Official forms & portals

Which current form, portal, account, and submission package must be used?

Compare countries

Official registration forms and the online services portal

forms.registration-forms-and-online-portal
Fact-level verified
Statement

DIGEMAPS registration transactions use numbered official forms: DGDF-RP-FO-001 for the registration application, DGDF-RP-FO-004 for a modification, DGDF-RP-FO-005 for the official technical sheet and DGDF-RP-FO-007 for the professional information sheet, each in the latest version published on the MSP website; the distributor habilitation file uses form FO-UBP-01 and advertising requests use DIGEMAPS-RS-LI-058. Applications are created online or filed at the Dirección de Gestión de Servicios al Usuario of the Ministry of Public Health, through the portal https://servicios.msp.gob.do/portal.

Source Approval

none

Target Jurisdiction Id

dominican-republic

Edge Type

No Reliance Route

Market Access Strength

none

Regulatory Layer

Premarket Review

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • New users must register on the services platform before filing.
  • Payment is made through a deposit or certified cheque at Banco de Reservas to the Tesorería Nacional account, and the receipt must not be older than three months.

Spanish. The MSP service listing (page_id=6279) supplies the portal address and the deposit instructions: 'Completar el formulario digital a través del siguiente enlace: https://servicios.msp.gob.do/portal/Account/Register'. Form DGDF-RP-FO-004 is cited on the DIGEMAPS modification service page, FO-UBP-01 on the distributor page and DIGEMAPS-RS-LI-058 on the advertising page.

QMS, audit & inspection

Which QMS, audit, inspection, and certificate scope is accepted or required?

Compare countries

GMP evidence and inspection of manufacturing laboratories

qms.gmp-certificate-and-laboratory-inspection
Fact-level verified
Statement

Registration and renewal of a sanitary product require a current good-manufacturing-practices certificate, or a quality-system certification corresponding to the product's classification, of the manufacturing/packaging laboratory — legalised or apostilled where imported. DIGEMAPS's Dirección de Vigilancia Sanitaria operates a dedicated GMP-inspection service addressed to manufacturing laboratories of medicines and sanitary products in all their classifications, at RD$ 25,000 per inspection area, with a stated response time of 40 working days, on the legal basis of Ley 42-01, Decreto 246-06 and the Normas particulares para la habilitación de los establecimientos farmacéuticos (2012).

Source Approval

none

Target Jurisdiction Id

dominican-republic

Edge Type

No Reliance Route

Market Access Strength

none

Regulatory Layer

Market Oversight

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • For imported products the GMP certificate must come from the origin-country authority and be legalised or apostilled.
  • The inspection fee is RD$ 25,000.00 per inspection area, and the areas enumerated on the service page are: manufacturers of medicines (synthetic or natural origin); primary packaging laboratories for medicines; enteral and parenteral nutrition mixing centres; manufacturers of sanitary products; manufacturers of raw materials; manufacturers of biological products.
  • A separate service exists for certification of storage and operability of logistic warehouses.
  • The service page's addressee is 'Laboratorios fabricantes de medicamentos y productos sanitarios', so the service covers device manufacturing laboratories, not the device registration applicant.

Spanish. Round 204 held this row source-backed-partial because the existence of the DIGEMAPS GMP-inspection service was drawn from the DIGEMAPS services index rather than a single instrument. Round 209 retrieved the service page itself and read it in full; its sections state: Descripción del servicio — 'Consiste en evaluar las buenas practicas de fabricaión de medicamentos en todas sus categorias y productos santiarios en toda sus clasificaciones.'; ¿A quién va dirigido? — 'Laboratorios fabricantes de medicamentos y productos sanitarios.'; Departamento que lo ofrece — 'DIGEMAPS – Dirección de Vigilancia Sanitaria'; Base Legal — 'Ley General de Salud Pública 42-01', 'Reglamento de medicamantos, que regula la fabricación, control de calidad, distribución, comercialización, importación y uso de medicamentos en la R.D., No. 246-06', 'Normas particulares para la habilitación de los establecimientos farmacéuticos, 2012.'; Costo — 'RD$ 25,000.00 por cada área de inspección siguiente: Fabricantes de medicamentos (de síntesis o de origen natural); laboratorios acondicionadores primarios de medicamentos; Centros de preparación de mezclas de nutrición enteral y parenteral; Fabricantes de productos sanitarios; Fabricantes de materia prima; Fabricantes de productos biológicos.'; Tiempo de respuesta — '40 días laborables'. The orthographic slips ('practicas', 'fabricaión', 'santiarios', 'medicamantos') are reproduced as published.

Recall, FSCA & market surveillance

Which recall, FSCA, notice, and authority-coordination duties apply?

Compare countries

DIGEMAPS publishes safety alerts and market withdrawals

recall.safety-alerts-and-market-withdrawal
Fact-level verified
Statement

DIGEMAPS maintains a public 'Alerta Sanitaria de Seguridad' register through which it publishes numbered sanitary alerts and market withdrawals (alerts numbered FVA-YYYY-NNNN) covering medicines, food and medical devices. The register is the publication channel for field safety corrective actions, including the 26 March 2026 withdrawal of the Ivascular Navitian coronary microcatheter under alert FVA-2026-0004, announced as a voluntary field safety corrective action by the manufacturer and its Dominican distributor, for which DIGEMAPS listed the eight affected lots with their expiry dates and directed health professionals and health establishments to report suspected adverse events to its farmacovigilancia address.

Source Approval

none

Target Jurisdiction Id

dominican-republic

Edge Type

No Reliance Route

Market Access Strength

none

Regulatory Layer

Market Oversight

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • Ley 42-01 art. 116 Párrafo I additionally allows the authority to suspend or revoke an authorisation for grave public-health cause or product-quality deficiencies, and obliges importers, manufacturers and health professionals to report adverse effects caused by medicines and other sanitary products.
  • Ley 42-01 arts. 150-151 (Libro Sexto, Título III, Capítulo I 'De las Inspecciones') give SESPAS inspectors the power to visit industrial, commercial, educational and medical-care establishments and other places, to collect samples and to carry out other measures prescribed by the law or by the competent sanitary authority.
  • The register is a publication channel, not a recall procedure instrument. The withdrawal procedure found in Decreto 246-06 (Comisión de Retiro y Restricción de Medicamentos, arts. 69-72; holder's duty to notify lot withdrawals, art. 67) is medicines-scoped, and no device-specific recall procedure instrument was located.
  • No device-specific post-market surveillance reporting cadence or recall-reporting deadline was found.

Spanish. Round 204 held this row source-backed-partial because the alerts it could sample were medicine and food alerts rather than device alerts. Round 209 read the register's table and the device alert itself. Register table entries read on 2026-09-16: 'Alerta retiro CYTOSAR' (20-05-2025); 'Alerta Sanitaria FVA-2024-0008' (19-12-2024); 'Alerta FVA 2024-0006, Falsificacion Producto Evital' — 'Alerta de falsificación del producto Evital.' (03-10-2024); 'Alerta FVA 2024-0005, Dexametasona' — 'Alerta del retiro voluntario del medicamento Dexametasona, solución inyectable' (30-09-2024); 'Alerta FVA 2024-0004, productos Boar's Head' (02-08-2024). The device alert (supporting source) reads: 'DIGEMAPS informa a la población el retiro del producto Microcatéter Coronario Ivascular Navitian, modelos MCCC1415001 y MCCC14150001, debido a una acción correctiva de seguridad. Mediante alerta sanitaria FVA-2026-0004, la DIGEMAPS explica que es voluntario el retiro del Microcatéter Coronario Ivascular Navitian, fabricado por Life Vascular Devices Biotech S.L. y comercializado por la empresa Ivascular Dominicana S.R.L., al reconocer una acción correctiva de seguridad de campo.' — 'DIGEMAPS informs the public of the market withdrawal of the Ivascular Navitian coronary microcatheter, models MCCC1415001 and MCCC14150001, due to a safety corrective action. Through sanitary alert FVA-2026-0004, DIGEMAPS explains that the withdrawal of the Ivascular Navitian coronary microcatheter is voluntary, recognising a field safety corrective action; it is manufactured by Life Vascular Devices Biotech S.L. and marketed by the company Ivascular Dominicana S.R.L.' The page lists eight affected lots with expiry dates (2505345, 2305219, 2305223, 2402340, 2408944, 2303095, 2406475, 2401439) and directs reports to farmacovigilancia@digemaps.gob.do. The device alert is a news item on the DIGEMAPS site and is not itself one of the five rows in the 'Alerta Sanitaria de Seguridad' register table.

Registration pathways

Which registration, notification, listing, reliance, or conformity route applies?

Compare countries

Sanitary registration is mandatory before import, distribution or use

pathway.sanitary-registration-mandatory
Fact-level verified
Statement

Obtaining a sanitary registration (registro sanitario) is obligatory for the manufacture, production, import, packaging, storage, transport, promotion, distribution and use of sanitary products in the Dominican Republic; DIGEMAPS evaluates the application and issues a certificate.

Source Approval

none

Target Jurisdiction Id

dominican-republic

Edge Type

No Reliance Route

Market Access Strength

none

Regulatory Layer

Premarket Review

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • Ley 42-01 Art. 109(b) assigns the health authority the sanitary control of the process, use, maintenance, import, export and final disposal of medical equipment, prostheses, orthoses, functional aids, diagnostic agents, dental supplies, surgical and healing materials and hygiene products; Art. 110's express prior-registration prohibition is drafted for 'medicamentos, cosméticos, productos de higiene personal y del hogar' and does not name the Art. 109(b) device families, so the device registration duty rests on Art. 109(b) read with DIGEMAPS's service rules.
  • Renewal is a separate transaction; the authorisation is temporary (Art. 116).

Spanish. English: 'Obtaining the Sanitary Registration. This requirement is obligatory for the elaboration, manufacture, production, import, packaging, storage, transport, promotion, distribution and use of sanitary products in the country.' The same page confirms that the certificate is the result of the service ('Resultado del servicio: Certificado' on the MSP listing).

Transactions eligible for the simplified procedure

pathway.simplified-procedure-transaction-scope
Fact-level verified
Statement

The simplified procedure is available for new registrations and renewals of existing registrations, and also for modifications to a manufacturer's installations, substantial changes to the technical data sheet, changes to packaging and conditioning materials, changes to the product information system, changes to the manufacturing and control process, and changes to excipients that do not affect bioavailability. It is not a separate marketing authorisation: it is a procedural track within the sanitary registration.

Source Approval

none

Target Jurisdiction Id

dominican-republic

Edge Type

No Reliance Route

Market Access Strength

none

Regulatory Layer

Premarket Review

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • Eligibility criteria for new registrations and renewals are set by SEGUNDO of the same resolution (see the reliance facts).
  • The MSP's published service listing for the simplified procedure covers the 'Productos Sanitarios' modality.

Effective from 2016-04-01

Spanish. Read from the scanned original by OCR. English: 'PRIMERO: The following transactions are eligible for sanitary registration by simplified procedure: a) modifications to the manufacturer's installations…; g) new registrations; h) renewals of existing registrations.'

Reliance & recognition

Which foreign decisions or evidence can be reused, with what effect and conditions?

Compare countries

Existing records include acceptance, restrictions and evidence reuse. The applicable product scope and conditions are preserved below; a reference does not by itself confer market access.

Dominican Republic approvals and evidence in other markets (0 records)

No linked record is currently maintained. This does not establish that a pathway is unavailable.

Prior approvals and evidence for Dominican Republic (5 records)

Dominican RepublicUS FDA · Health Canada · Japan MHLW / PMDA · Australia TGA · EU conformity assessment · Iceland · Norway

Prior approval / evidence record

WHO Strict Authorities — US FDA, Health Canada, Japan NIHS, Australia TGA, EMA, Icelandic Medicines Agency, Norwegian Medicines Agency, Liechtenstein AML

Authority

WHO Strict Authorities — US FDA, Health Canada, Japan NIHS, Australia TGA, EMA, Icelandic Medicines Agency, Norwegian Medicines Agency, Liechtenstein AML

Accepted

Yes

Benefit

Eligibility for the simplified registration procedure under Resolución No. 000004 on a Certificate of Free Sale plus a good-manufacturing-practices certificate from that authority, for new registrations and renewals of imported products; the remaining legal requirements still apply and DIGEMAPS retains the decision.

Timeline Savings

No published period: the MSP service listing shows 'Inmediatamente' rather than a number of days.

Maintained reference · planning ranges remain estimates · reviewed 2026-09-16

Dominican RepublicSource authority not specified

Prior approval / evidence record

Origin-country free-sale certificate and manufacturer GMP certificate required in the dossier

reliance.origin-country-free-sale-certificate-mandatory
Fact-level verified
Statement

For an imported device, the sanitary-registration dossier must include a current original certificate of free sale for the product issued by the health authority of the country of origin, legalised or apostilled, and a current original good-manufacturing-practices certificate (or quality-system certification) of the manufacturing laboratory, legalised or apostilled. These are mandatory supporting documents for the full local review; they do not by themselves shorten the review, which is only shortened where the issuing authority is one of the listed Strict Authorities or ARNr.

Source Approval

Certificate of free sale from the health authority of the country of origin (any origin country; no specific reference authority required)

Edge Type

Origin Country Evidence

Market Access Strength

Evidence Only

Regulatory Layer

Premarket Review

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • Applies to imported products; national products instead file the manufacturer's national GMP certificate.
  • In maquila cases a manufacturing certification issued by the origin-country health authority is additionally required.
  • The documents must be legalised or apostilled.
  • The same origin-country documents are required again on renewal and on automatic renewal.

Spanish (source language), quoted in the original. English: 'Current original certificate of free sale of the product, issued by the health authority of the country of origin, legalised or apostilled (Imports).' and 'Current original certificate of good manufacturing practices of the manufacturing/packaging laboratory, or certification of the quality system used corresponding to the classification of the requested product, legalised or apostilled (Imports).' The renewal page repeats the same two requirements and adds the requirement that documents in a language other than Spanish be translated by a judicial interpreter.

Dominican RepublicJapan MHLW / PMDA · South Korea MFDS

Prior approval / evidence record

Japan PMDA and Korea MFDS

Authority

Japan PMDA and Korea MFDS

Accepted

No

Benefit

Neither is named in the Resolución No. 000004 recognition list — Japan appears there only as NIHS — so a PMDA or MFDS marketing approval confers no simplified-procedure eligibility and the application is assessed under the ordinary route. DIGEMAPS' IMDRF affiliate membership creates no recognition route.

Maintained reference · planning ranges remain estimates · reviewed 2026-09-16

Dominican RepublicBrazil ANVISA

Prior approval / evidence record

PAHO/PARF regional reference authorities (ARNr) — ANMAT, ANVISA, CECMED, INVIMA, COFEPRIS

Authority

PAHO/PARF regional reference authorities (ARNr) — ANMAT, ANVISA, CECMED, INVIMA, COFEPRIS

Accepted

Yes

Benefit

Same simplified-procedure eligibility as the WHO Strict Authorities under Resolución No. 000004.

Timeline Savings

No published period.

Maintained reference · planning ranges remain estimates · reviewed 2026-09-16

Dominican RepublicUS FDA · Health Canada · Japan MHLW / PMDA · Australia TGA · EU conformity assessment · Iceland · Norway · Brazil ANVISA

Prior approval / evidence record

Simplified registration for imported products previously authorised by a WHO Strict Authority or a PAHO/PARF regional reference authority

reliance.strict-authority-prior-authorisation-simplified-procedure
Fact-level verified
Statement

An imported product that has previously been authorised by a WHO Strict Authority or by a regional reference regulatory authority (ARNr) of the PAHO/PARF network may be registered through the simplified procedure, evidenced by a Certificate of Free Sale and a Certificate of Good Manufacturing Practices issued by that authority, in addition to the other requirements of current legislation. Products that any of those authorities has refused to authorise are excluded from the simplified procedure.

Source Approval

WHO Strict Authorities: US FDA; Health Canada; Japan NIHS (National Institute of Health Science); Australia TGA; EMA; Icelandic Medicines Agency; Norwegian Medicines Agency; Liechtenstein (Amt für Lebensmittelkontrolle und Veterinärwesen). PAHO/PARF regional reference authorities (ARNr): ANMAT (Argentina), ANVISA (Brazil), CECMED (Cuba), INVIMA (Colombia), COFEPRIS (Mexico)

Edge Type

Abridged Or Recognition Route

Market Access Strength

facilitated

Regulatory Layer

Premarket Review

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • Eligibility runs to 'nuevos registros sanitarios y renovaciones' (new registrations and renewals of existing registrations) of imported products.
  • The prior authorisation is evidenced by a Certificate of Free Sale plus a Certificate of Good Manufacturing Practices issued by the listed authority; the rest of the legally established requirements still apply.
  • A product that one of the listed authorities has refused to authorise may not use the simplified procedure (CUARTO).
  • Products identified as having quality failures in post-market monitoring or serious safety reports are excluded (PÁRRAFO of SEGUNDO).
  • Resolution in force from 1 April 2016 (SEXTO).
  • The resolution is drafted around the medicines framework; the MSP service listing for the simplified procedure expressly covers 'Productos Sanitarios' with its own fee, but the MSP listing shows Productos Sanitarios under the renewal modality only, while the fee table lists them under both new and renewal — the scoping for new device registrations is therefore stated by the MSP rather than by the resolution text itself.

Effective from 2016-04-01

Spanish. Source PDF is an image-only scan (Adobe 'Image Conversion Plug-in'); the passage below was read from the scan by OCR and OCR spacing artefacts were normalised. Original: "Productos importados que previamente hayan sido autorizados por Autoridades Estrictas (OMS) y/o de Autoridades Reguladoras de Referencia Regional (ARNr) de la Red Panamericana para la Armonización de la Reglamentación Farmacéutica (RED PARF/OPS), lo cual debe ser avalado mediante la presentación del 1. Certificado de Libre Venta y Certificado de Buenas Prácticas de Manufactura emitido por las referidas autoridades en adición a los demás requisitos establecidos en la legislación vigente." English: imported products previously authorised by WHO Strict Authorities and/or PAHO/PARF regional reference authorities, evidenced by the free-sale and GMP certificates issued by those authorities, in addition to the other requirements of current legislation. The recognised-authority list (TERCERO) names FDA, Health Canada, NIHS, TGA, EMA, the Icelandic and Norwegian medicines agencies and Liechtenstein as Strict Authorities, and ANMAT, ANVISA, CECMED, INVIMA and COFEPRIS as ARNr.

Review clocks

What review, validation, and applicant stop-clock rules apply?

Compare countries

If DIGEMAPS finds a discrepancy after an automatic renewal, the holder must file the modification within a non-extendable 15 calendar days (Decreto 45-23, Art. 2 Párrafo II)

clocks.fifteen-calendar-days-to-file-modification-after-renewal-discrepancy
Fact-level verified

Renewal of sanitary registrations of productos sanitarios is automatic once the renewal fee is paid and the registration is still valid; where DIGEMAPS establishes a discrepancy or modification in the product relative to the automatically renewed registration, it notifies the user, who must submit the registration-modification procedure within a non-extendable period of 15 calendar days, without prejudice to statutory sanctions.

Conditions
  • Calendar days, non-extendable.
  • Applies after an automatic renewal under Decreto 117-18 as amended.

Effective from 2023-02-14

English gist: 15-calendar-day non-extendable clock to file a modification after DIGEMAPS detects a post-renewal discrepancy. Complements the existing renewal facts from Decreto 45-23 Arts. 2–5.

Published response time for a sanitary-product registration

clocks.registration-response-time-90-business-days
Fact-level verified
Statement

DIGEMAPS publishes a response time of 90 business days for the sanitary registration of sanitary products, and the same 90 business days for renewal.

Source Approval

none

Target Jurisdiction Id

dominican-republic

Edge Type

No Reliance Route

Market Access Strength

none

Regulatory Layer

Premarket Review

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • This is the published service standard; the statutory outer limit in Ley 42-01 Art. 115 (60 to 90 days, with issuance or refusal at the latest 90 days after a complete application) is expressed for medicines and their registration.
  • Review clocks are due for re-verification after 12 months under the review policy.

Spanish. The service page states 'Tiempo de respuesta: 90 días laborables' and the renewal page states the same. English: 'Response time: 90 business days.' Ley 42-01 Art. 115 provides that 'El proceso de autorización y registro deberá realizarse en el plazo de 60 a 90 días.'

An applicant has ten days to cure an incomplete application, extendable by up to five days, or is deemed to have withdrawn (Ley 107-13, Art. 23 Párrafo IV)

clocks.ten-day-cure-period-for-incomplete-applications
Fact-level verified

When an application lacks the required elements, the competent organ informs the applicant so that the omissions can be cured within ten days; failing that, withdrawal is declared unless the period was reasonably extended by no more than five days at the applicant's request. DIGEMAPS' own service procedure likewise has the Dirección de Gestión de Servicios al Usuario notify missing data or documents before acceptance and allows non-conforming files to be re-entered after the observations are completed.

Conditions
  • Days are business days under Art. 20 Párrafo I.
  • General law; the DIGEMAPS page does not publish a shorter or longer cure period.

Effective from 2013-08-06

English gist: 10-day cure period for deficient applications, extendable by up to 5 days, otherwise deemed withdrawn.

Where sectoral rules set no period, the supplementary deadline to decide an administrative procedure is two months, extendable by at most one month (Ley 107-13, Art. 20 Párrafo III)

clocks.two-month-supplementary-deadline-administrative-procedure
Fact-level verified

Ley 107-13 requires each procedure's regulation to set a reasonable processing period; where the governing rules provide no specific period, the supplementary period is two months and no extension may exceed one month. Periods run from the day after notification or publication and, unless stated otherwise, are counted in business days excluding Saturdays, Sundays and holidays (Párrafos I–II).

Conditions
  • General administrative-procedure law applicable to the Ministry of Health / DIGEMAPS; sectoral periods such as the published 90 business days prevail where they exist.
  • Unjustified breach of periods gives a right to compensation (Art. 20).

Effective from 2013-08-06

English gist: default two-month decision period (max one-month extension) when no specific period exists; day-counting rules in business days.

Special access & derogation

Is an emergency, compassionate, custom, humanitarian, or other exceptional path available?

Compare countries

Emergency dispensation from the sanitary-control regulations

special-access.emergency-dispensation-of-sanitary-control
Fact-level verified
Statement

Dominican law empowers the health authority, in situations of emergency resulting from a disaster of any origin, to dispense temporarily with the application of the sanitary-control regulations. The power sits in the common-provisions chapter of the sanitary-control book, in which the health authority is assigned the sanitary control of the process, use, maintenance, import, export and final disposal of medical equipment, prostheses, orthoses, functional aids, diagnostic agents, dental supplies and surgical and healing materials, so those products are within the chapter's subject matter.

Article

Art. 113 (con Art. 109(b))

Conditions
  • The dispensation is temporary, is triggered by an emergency situation arising from a disaster of any origin, and is granted by the Secretaría de Estado de Salud Pública y Asistencia Social — today the Ministerio de Salud Pública, exercised through DIGEMAPS — not by application of the importer.
  • Art. 113 is the last article of Libro Cuarto, Título Único, Capítulo I 'Disposiciones Comunes' (arts. 109-113); art. 109(b) enumerates the products covered by the health authority's sanitary control as 'equipos médicos, prótesis, ortesis, ayudas funcionales, agentes de diagnóstico, insumos de uso odontológico, materiales quirúrgicos y de curación y productos higiénicos'.
  • The operational named-patient route located is medicines-only and is recorded as a scope caveat, not as the device answer: Decreto 246-06 art. 116 subjects imports of unregistered medicines needed for the treatment of a specific person, products in clinical-investigation phase and donations to the express authorisations of the Dirección General de Drogas y Farmacias, and its Párrafo I allows the State to import unregistered medicines when there is a Declaratoria de Emergencia putting public health at risk.
  • No device-specific compassionate-use, expanded-access or emergency-import procedure was found: the DIGEMAPS service catalogue contains no such service page, and no such instrument appears among the DIGEMAPS laws, decrees and resolutions published in its downloads register.

Spanish; the PDF carries the publisher's OCR text layer with character-substitution artefacts, preserved verbatim in the excerpt. Normalised: 'Art. 113.- En caso de situaciones de emergencia, como resultado de un desastre de cualquier origen, la SESPAS podrá dispensar temporalmente la aplicación de los reglamentos del control sanitario.' — 'In case of emergency situations resulting from a disaster of any origin, SESPAS may temporarily dispense with the application of the sanitary-control regulations.' Art. 109(b), verbatim: 'El control sanitario del proceso, el USO, el mantenimiento, la irnportacion, la exportacion y la disposicion final de equipos medicos, protesis, ortesis, ayudas funcionales, agentes de diagnostico, insumos de us0 odontologico, materiales quinirgicos y de curacion y productos higienicos.' — 'The sanitary control of the process, use, maintenance, import, export and final disposal of medical equipment, prostheses, orthoses, functional aids, diagnostic agents, dental supplies, surgical and healing materials and hygiene products.' The medicines-only operational counterpart, Decreto 246-06 art. 116 Párrafo I, verbatim: 'El Estado podra importar medicamentos sin registro sanitario cuando exista una Declaratoria de Emergencia que ponga en riesgo la salud de la poblacihn.'

Standards, testing & ancillary approvals

Which standards, tests, and radio, electrical, metrology, or other overlays are triggered?

Compare countries

Updates to the finished-product QC method and specifications of productos sanitarios may be filed as a sworn-declaration sanitary notification when approved guarantees are unchanged (Res. 000011-17, CUARTO)

standards.qc-method-and-specification-updates-by-sanitary-notification
Fact-level verified

Resolución 000011 (25 July 2017) defines sanitary notification as a sworn-declaration procedure to update a valid registration and lists among eligible updates the quality-control method and finished-product specifications for medicines, cosmetics, hygiene products, productos sanitarios, natural products and foods, provided the approved guarantees of identification, quality, purity and stability are not modified; DIGEMAPS denies notifications not accompanied by the required documents (SÉPTIMO).

Conditions
  • Only where the approved guarantees relating to identification, quality, purity and stability are not modified.
  • Packaging-design and insert-format updates are the other eligible category.

Effective from 2017-07-25

English gist: QC-method and specification updates go through the sworn-declaration notification route when quality guarantees are unchanged. Transcribed from the scanned resolution (OCR checked against the page). Also relevant to change-control.

Submission communications & appeal

How are deficiencies answered, clocks handled, and decisions escalated or appealed?

Compare countries

Administrative reconsideration and hierarchical review against a decision

appeal.administrative-reconsideration-and-hierarchical-review
Fact-level verified
Statement

Administrative acts that end a procedure, prevent its continuation, produce defenselessness, harm subjective rights or cause irreparable damage may be challenged directly by the administrative route. The person may file a recurso de reconsideración before the organ that issued the act, which must decide within thirty days, and a recurso jerárquico before the competent Minister — in the central administration — without needing to have filed a reconsideración first, which must equally be decided within thirty days. If either appeal is not decided within the period, the interested party may treat it as tacitly denied and go, at its option, to the contentious-administrative jurisdiction without a preclusive deadline. Administrative appeals are optional, and filing one does not suspend the challenged act, although the reviewing organ may order its suspension of its own motion or on request.

Article

Arts. 47, 49, 50, 51, 53 y 54

Conditions
  • Ley 107-13 is the general administrative-procedure statute of the Dominican State; it creates the remedy available against DIGEMAPS and MSP decisions, not a DIGEMAPS-specific appeal, and is cited as the general remedy.
  • The reviewing organ may confirm, modify or revoke the challenged act, or order the procedure to be re-run for procedural defects, and may never worsen the legal position of the appellant (art. 52).
  • Suspension of the challenged act may be granted where execution could cause grave harm to the interested party or where the challenge is founded on nullity by operation of law, and a guarantee may be required (art. 50).
  • The choice of the contentious-administrative route makes the administrative appeal unavailable, but filing an administrative appeal does not prevent later going to the courts once it is decided or the decision period has run (art. 51).

Spanish. Art. 53, verbatim: 'Los actos administrativos podrán ser recurridos ante los órganos que los dictaron en el mismo plazo de que disponen las personas para recurrirlos a la vía contencioso-administrativa.' and its Párrafo: 'El órgano competente para resolver el recurso administrativo dispondrá de un plazo de treinta (30) días para dictar su decisión. Si el recurso de reconsideración no fuera resuelto dentro del plazo fijado, el interesado podrá reputarlo denegando tácitamente, pudiendo interponer a su opción el recurso jerárquico, si procede, o el contencioso administrativo, sin plazo preclusivo.' Art. 54, verbatim: 'Contra los actos dictados por órganos sujetos al control jerárquico de otros superiores podrá interponerse recurso jerárquico, sin que sea necesario haber deducido previamente recurso de reconsideración.' and Párrafo III: 'La interposición de un recurso jerárquico tendrá que efectuarse en el mismo plazo de que disponen las personas para interponer el recurso contencioso administrativo. El recurso deberá ser en todo caso resuelto en un plazo no mayor de treinta (30) días. Si el recurso jerárquico no fuera resuelto dentro del plazo fijado, el interesado podrá reputarlo denegado tácitamente, pudiendo interponer, sin plazo preclusivo, el recurso contencioso administrativo.' Art. 47, verbatim: 'Los actos administrativos que pongan fin a un procedimiento, imposibiliten su continuación, produzcan indefensión, lesionen derechos subjetivos o produzcan daños irreparables podrán ser directamente recurridos en vía administrativa.' The source is the full text of Ley No. 107-13 published by the Poder Judicial of the Dominican Republic; its heading reads 'Ley No. 107-13 sobre los Derechos de las Personas en sus Relaciones con la Administración y de Procedimiento Administrativo. G. O. No. 10722 del 8 de agosto de 2013.'

Completeness check, deficiency notice and re-entry of a sanitary registration application

submission.deficiency-notice-and-re-entry
Fact-level verified
Statement

A sanitary-registration application for a sanitary product is prepared from DIGEMAPS's published requirements list and filed online or in person at the Dirección de Gestión de Servicios al Usuario of the Ministerio de Salud Pública. That directorate confirms whether the application is complete — accepting it if it is, and notifying the applicant of the missing data or documentation if it is not — and the application is then entered and sent to DIGEMAPS for evaluation in the corresponding area, with the answer returned through the same directorate for delivery to the applicant. An application that was found non-conforming may be re-entered once the applicant has completed the observations received.

Article

Procedimiento a seguir

Conditions
  • The same 'Procedimiento a seguir' text is published on both the registration and the renewal service pages for sanitary products, so the deficiency-and-re-entry route applies to renewal as well as to first registration.
  • The procedure described is an administrative completeness check at the front office; it does not state any substantive right of reply, hearing or appeal against a refusal, which is why the general administrative remedies are recorded as a separate fact.
  • The registration service page also fixes the fee at RD$ 9,000 'Para Medicamento' and the response time at 90 días laborables; those are D14/D15 material and are not claimed here.

Spanish. Verbatim from the registration service page, 'Procedimiento a seguir': 'La Dirección de Gestion de Servicios al Usuario confirma si la solicitud está completa, en caso de estar completa la acepta y en caso de que no, notifica al usuario cuales son los datos o documentación faltante para ser completada.' and 'En el caso de las solicitudes no conformes, después que el usuario completa las observaciones recibidas, puede reingresar la solicitud.' — 'The Dirección de Gestión de Servicios al Usuario confirms whether the application is complete; if it is complete it accepts it, and if it is not it notifies the user of the data or documentation missing for it to be completed.' / 'In the case of non-conforming applications, once the user has completed the observations received, the application may be re-entered.' The same page's 'Descripción del servicio' states: 'Obtención del Registro Sanitario. Este requisito es obligatorio para la elaboración, fabricación, producción, importación, envase, almacenamiento, transportación, promoción, distribución y uso de los productos sanitarios en el país.'

UDI, listing & traceability

Which UDI, device listing, database, and traceability duties apply?

Compare countries

Lot-level traceability records for imported and distributed products

traceability.importer-and-distributor-lot-records
Fact-level verified
Statement

Decreto 246-06 obliges the technical director of an importing establishment to establish traceability records of the products brought in and to record which establishments they are destined for, in accordance with good-distribution practices, and obliges distribution establishments to keep absolute control of the provenance of the products and of their distribution by lot number or identification key — which the reglamento expressly names 'control y trazabilidad'. The importing establishment's technical director additionally guarantees the conformity of each product, lot by lot, to the specifications of the certificate of analysis.

Article

Art. 105, Párrafo (y primer párrafo); Art. 166(b)

Conditions
  • Scope: Decreto 246-06 art. 1 states that the reglamento 'también comprende ... los principios, normas, criterios, requerimientos y exigencias básicas relativas a seguridad, eficacia y calidad, de medicamentos, productos sanitarios, cosméticos, productos de higiene personal, productos farmacéuticos de origen natural ... y productos de higiene del hogar', and Capítulo IV (arts. 103-119) is headed 'De las Importaciones de Medicamentos, Cosméticos, Productos Sanitarios, Productos de Higiene Personal y del Hogar'. Art. 166(b)'s closing sentence, however, names 'medicamentos y productos farmacéuticos', so the duty reaches a medical device through the reglamento's express product-scope extension rather than by naming devices.
  • Both DIGEMAPS service pages for sanitary products cite Decreto 246-06 as their base legal, which is the national administrative practice applying the reglamento to productos sanitarios.
  • No UDI rule was found. No Dominican instrument read imposes a unique device identifier, a UDI database, or a device listing separate from the sanitary registration; the DIGEMAPS service catalogue contains no UDI service, and the sanitary-product registration service page describes no UDI data element among its requirements.

Spanish. The retrieved PDF carries the publisher's OCR text layer with character-substitution artefacts ('10s' for 'los', 'distribucihn' for 'distribución', 'estin' for 'están'), preserved verbatim in the excerpt. Art. 105, Párrafo, normalised: 'Párrafo: Los directores técnicos de los establecimientos importadores están obligados a establecer registros de trazabilidad de los productos de entrada y registrar a qué establecimientos van destinados, de acuerdo a las prácticas de correcta distribución.' — 'The technical directors of importing establishments are obliged to establish traceability records of incoming products and to record which establishments they are destined for, in accordance with good-distribution practices.' The counterpart duty, Art. 166(b), verbatim: 'Se tenga, de una manera fehaciente, un absoluto control de la procedencia de los productos y de su distribución, por número de lote o clave de identificación. Esto se denominará control y trazabilidad de los medicamentos y productos farmacéuticos.' — 'There shall be, in a reliable manner, absolute control of the provenance of the products and of their distribution, by lot number or identification key. This shall be called control and traceability of medicines and pharmaceutical products.' Art. 105, first paragraph, verbatim: 'El director tecnico farmaceutico del establecimiento importador garantizara la adecuacihn de cada producto, por lote o lotes objeto del procedimiento, a las especificaciones referidas en el Certificado Analitico'. The reglamento's definition 45 (FABRICACIÓN FARMACÉUTICA) also refers to 'los procesos de control de calidad y trazabilidad documental'.

Vigilance & incident reporting

What is reportable, by whom, where, in what format, and by what deadline?

Compare countries

Importers, manufacturers and health professionals must report adverse effects

vigilance.adverse-effect-reporting-duty
Fact-level verified
Statement

Under the Ley General de Salud, importers, manufacturers and health professionals are obliged to communicate the adverse effects caused by medicines and other sanitary products whenever a danger to life or health may derive from them, or where the therapeutic effect proves invalid or fails to produce the expected effects. DIGEMAPS has strengthened post-market surveillance so that any adverse event on a medical device is identified and managed quickly.

Source Approval

none

Target Jurisdiction Id

dominican-republic

Edge Type

No Reliance Route

Market Access Strength

none

Regulatory Layer

Market Oversight

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • The obligation is stated in the provision that also empowers suspension or revocation of an authorisation for grave public-health cause or quality deficiencies.
  • Renewal and automatic renewal require proof that pharmacovigilance information has been deposited with DIGEMAPS' Departamento de Vigilancia Sanitaria.

Spanish. English: 'To that end, importers, manufacturers and health professionals have the obligation to communicate the adverse effects caused by medicines and other sanitary products, when a danger to the life or health of persons may derive from them, or where it is verified that their therapeutic effect is not valid or does not produce the expected effects.' The post-market-surveillance sentence is from the DIGEMAPS IMDRF announcement: 'También ha fortalecido la "Vigilancia poscomercialización" integrando las pautas que garanticen que cualquier evento adverso se identifique y se gestione rápidamente, manteniendo la seguridad de los dispositivos médicos en el mercado.'

Related structured datasets

Classification systems · 0 records

No maintained record.

Registration pathways, prior approvals and planning · 1 record
Open Dominican Republic registration
Country

Dominican Republic

Jurisdiction Id

dominican-republic

Country Code

DO

Flag

🇩🇴

Regulator

Dirección General de Medicamentos, Alimentos y Productos Sanitarios (DIGEMAPS), Ministerio de Salud Pública y Asistencia Social

Regulator Abbrev

DIGEMAPS

Region

americas

Tier

3

Risk Classification

No in-force device risk-class axis: the registration dossier requires the applicant to declare the product's 'nivel de riesgo' and the GMP certificate 'correspondiente a la clasificación del producto solicitado', but the class names (I, IIa, IIb, III) sit in a draft Reglamento Técnico de Productos Sanitarios y/o Dispositivos Médicos that is not in force. No timeline row therefore carries a riskLevel.

Classes
  • Id

    sanitary-registration-new

    Class Name

    Sanitary registration — new registration (all sanitary products)

    Pathway

    Registro Sanitario under Ley 42-01, Decreto 246-06 and Resolución 000020, filed on form DGDF-RP-FO-001 through the MSP Ventanilla Única de Servicios

    Official Timeline
    Min

    90

    Max

    90

    Unit

    working-days

    Verification Status

    official-verified

    Official Source
    Title

    DIGEMAPS — Registro sanitario de productos sanitarios: tiempo de respuesta (90 días laborables)

    Url

    https://digemaps.gob.do/servicios/registro-sanitario-de-productos-sanitarios/

    Accessed Date

    2026-09-16

    Realistic Timeline
    Min

    3

    Max

    6

    Notes
    • 'Tiempo de respuesta: 90 días laborables' is the figure DIGEMAPS publishes for the sanitary registration of sanitary products. It is a service standard, not a statutory maximum: Ley 42-01 Art. 115 sets a 60-to-90-day limit for medicines and their registration only, and no statutory period for sanitary products was found.
    • The service entry is device-specific: its '¿A quién va dirigido?' is 'Empresas que se dedican a la comercialización de productos sanitarios' and its requirements list names '(Dispositivos médicos)' twice, for product plans/schematics and for product-family applications. It is the only device decision clock found in this market.
    • The clock is not split by product class anywhere, because there is no in-force class axis to split it by.
    • A related but medicines-only period is deliberately NOT recorded as a device clock: Ley 42-01 Art. 115 Párrafo IX bars the holder from marketing a product for the ninety days after a reference-laboratory-based registration, and Decreto 246-06 Art. 63 gives one month for alegaciones after a denial. Both are medicines provisions and neither is a device review clock.
    Clinical Trial Required

    No

    Local Testing Required

    No

    Gmp Required

    Yes

  • Id

    sanitary-registration-renewal

    Class Name

    Sanitary registration — renewal (all sanitary products)

    Pathway

    Renovación del Registro Sanitario, filed within the three months before expiry; automatic on payment of the fee while the registration is in force

    Official Timeline
    Min

    90

    Max

    90

    Unit

    working-days

    Verification Status

    official-verified

    Official Source
    Title

    DIGEMAPS — Renovación de registro sanitario de productos sanitarios: tiempo de respuesta

    Url

    https://digemaps.gob.do/servicios/renovacion-de-registro-sanitario-de-productos-sanitarios/

    Accessed Date

    2026-09-16

    Realistic Timeline
    Min

    1

    Max

    3

    Notes
    • The renewal service page publishes the same 90 días laborables as the registration page.
    • CONTRADICTION BETWEEN THE PUBLISHED FIGURE AND THE GOVERNING INSTRUMENT, disclosed rather than resolved: Decreto 117-18 as amended by Decreto 45-23 Art. 2 provides that 'La renovación de los registros sanitarios de los alimentos, medicamentos, productos sanitarios, cosméticos, higiene personal y del hogar será automática' once the renewal fee is paid and the registration to be renewed is in force, and Art. 3 provides that the automatic renewal 'se realizará a partir del depósito de la solicitud'. On the automatic-renewal reading there is no substantive review of a renewal dossier, so a 90-working-day decision clock cannot describe the ordinary case — the published 90 days describes the service counter's handling time, not a review.
    • The 90 días laborables stays correct for the residual case in which DIGEMAPS finds a discrepancy against an automatically renewed registration and the holder must submit a modification, which is why the row keeps its officialTimeline.
    • Renewal is automatic provided the renewal fee has been paid and the registration to be renewed is in force; the holder must file within the three months before expiry, and a registration that reaches expiry without an application is cancelled with no right to an extension (Decreto 117-18 as amended by Decreto 45-23, Artículos 2-4).
    • Where the registration has changed in any way, the modification application must be filed together with the renewal and both fees paid; if DIGEMAPS finds a discrepancy against an automatically renewed registration the holder must submit the modification procedure within 15 calendar days (Art. 2 Párrafo II), and a modification filed within the six months before expiry causes the certificate to issue with automatic renewal (Art. 5).
    Clinical Trial Required

    No

    Local Testing Required

    No

    Gmp Required

    Yes

Prior Approvals
  • Authority

    WHO Strict Authorities — US FDA, Health Canada, Japan NIHS, Australia TGA, EMA, Icelandic Medicines Agency, Norwegian Medicines Agency, Liechtenstein AML

    Accepted

    Yes

    Benefit

    Eligibility for the simplified registration procedure under Resolución No. 000004 on a Certificate of Free Sale plus a good-manufacturing-practices certificate from that authority, for new registrations and renewals of imported products; the remaining legal requirements still apply and DIGEMAPS retains the decision.

    Timeline Savings

    No published period: the MSP service listing shows 'Inmediatamente' rather than a number of days.

  • Authority

    PAHO/PARF regional reference authorities (ARNr) — ANMAT, ANVISA, CECMED, INVIMA, COFEPRIS

    Accepted

    Yes

    Benefit

    Same simplified-procedure eligibility as the WHO Strict Authorities under Resolución No. 000004.

    Timeline Savings

    No published period.

  • Authority

    Japan PMDA and Korea MFDS

    Accepted

    No

    Benefit

    Neither is named in the Resolución No. 000004 recognition list — Japan appears there only as NIHS — so a PMDA or MFDS marketing approval confers no simplified-procedure eligibility and the application is assessed under the ordinary route. DIGEMAPS' IMDRF affiliate membership creates no recognition route.

Key Requirements
  • The application must be filed by a pharmaceutical establishment established as representative in the Dominican Republic under a power of representation that is notarised and certified before the Procuraduría for national applicants, or legalised or apostilled for imported products, and that establishment must hold a current sanitary registration (DIGEMAPS registration requirements).
  • An imported product requires a current original Certificate of Free Sale from the health authority of the country of origin and a current original good-manufacturing-practices or quality-system certificate of the manufacturing laboratory, both legalised or apostilled (DIGEMAPS registration requirements).
  • The dossier must include the official technical sheet (DGDF-RP-FO-005) and the professional information sheet (DGDF-RP-FO-007), professional-use information stating uses, indications, warnings, precautions, contraindications and the product's risk level, and two original finished-product samples with at least one year of validity.
  • The file must include the product description with main parts and specifications, plans or schematics for medical devices, technical studies and analytical checks with a summary of design tests and specifications, and an original certificate of analysis of the finished product matched to the deposited samples.
  • Documents in a language other than Spanish must be translated by a judicial interpreter, and labels, inserts and packaging must be filed as actually marketed.
  • Renewal must be filed within the three months before expiry; renewal is automatic on payment of the fee while the registration is in force, and the registration is cancelled with no right to an extension if it reaches expiry without an application (Decreto 117-18 as amended by Decreto 45-23).
  • Advertising and promotion of sanitary products to the general public requires authorisation or notification from DIGEMAPS under the reglamento brought into force by Resolución 000033-15.
  • Importers, manufacturers and health professionals must report adverse effects caused by sanitary products to DIGEMAPS whenever a danger to life or health may derive from them (Ley 42-01 Art. 116 Párrafo I).
Local Rep Required

Yes

Local Rep Name

Establecimiento farmacéutico representante — a pharmaceutical establishment registered as representative in the Dominican Republic, holding its own current establishment sanitary registration

Mdsap Accepted

No

Mdsap Benefit

No MDSAP acceptance was found. The dossier requires a good-manufacturing-practices or quality-system certificate of the manufacturing laboratory corresponding to the product's classification, legalised or apostilled for imported products, and DIGEMAPS runs its own GMP inspection service for sanitary-product laboratories.

Registration Validity

The authorisation is temporary and must be revalidated (Ley 42-01 Art. 116); in practice renewal is automatic on payment of the fee while the registration is in force, filed within the three months before expiry (Decreto 117-18 as amended by Decreto 45-23). No fixed term of years for sanitary products was evidenced.

Last Updated

2026-09-16

Verification Status

partially-verified

Official Sources
  • Title

    DIGEMAPS — Registro sanitario de productos sanitarios: tiempo de respuesta (90 días laborables)

    Url

    https://digemaps.gob.do/servicios/registro-sanitario-de-productos-sanitarios/

    Accessed Date

    2026-09-16

  • Title

    DIGEMAPS — Renovación de registro sanitario de productos sanitarios: tiempo de respuesta

    Url

    https://digemaps.gob.do/servicios/renovacion-de-registro-sanitario-de-productos-sanitarios/

    Accessed Date

    2026-09-16

  • Title

    MSP — Procedimiento simplificado: costo del servicio y tiempo de respuesta (Inmediatamente / según los requisitos)

    Url

    https://www.msp.gob.do/web?page_id=6279

    Accessed Date

    2026-09-16

  • Title

    Decreto núm. 45-23 que modifica el Decreto núm. 117-18 — renovación automática de registros sanitarios, Artículos 2, 3 y 4

    Url

    https://burocraciacero.gob.do/wp-content/uploads/2024/10/Decreto-45-23.pdf

    Accessed Date

    2026-09-16

  • Title

    Resolución No. 000004 del 27 de enero de 2016 — criterios para la aplicación del registro sanitario, venta libre y buenas prácticas de establecimientos

    Url

    https://digemaps.gob.do/descargas/17/resoluciones/34201/resolucion-num-000004-16-establece-criterios-para-la-aplicacion-del-registro-sanitario-venta-libre-y-buenas-practicas-de-establecimientos.pdf

    Accessed Date

    2026-09-16

Reviewed On

2026-09-16

Process
Template Id

default

Status

planning-template

Usage Rule

Maintained planning steps and estimates, not verified regulator deadlines.

Steps
  • Step

    1

    Title

    Pre-Submission Preparation

    Description

    Gather technical documentation, quality management system (QMS) records, and clinical data required by DIGEMAPS. Appoint a Establecimiento farmacéutico representante — a pharmaceutical establishment registered as representative in the Dominican Republic, holding its own current establishment sanitary registration.

    Duration

    1-3 months

    Icon

    📋

  • Step

    2

    Title

    Application Submission

    Description

    Submit complete registration dossier to DIGEMAPS including device description, risk analysis, and testing reports.

    Duration

    1-2 weeks

    Icon

    📤

  • Step

    3

    Title

    Administrative Review

    Description

    DIGEMAPS reviews application for completeness. May request additional documents or clarifications.

    Duration

    2-4 weeks

    Icon

    🔍

  • Step

    4

    Title

    Technical Evaluation

    Description

    In-depth technical assessment of device safety and performance. DIGEMAPS may issue questions.

    Duration

    90 working days

    Icon

    ⚙️

  • Step

    5

    Title

    Registration Approval

    Description

    Upon successful review, DIGEMAPS issues Dominican Republic market authorization certificate.

    Duration

    1-2 weeks

    Icon

Government fee schedules · 1 record
Open Dominican Republic fees
Jurisdiction Id

dominican-republic

Country

Dominican Republic

Country Code

DO

Authority

DIGEMAPS

Low Risk Local
Min

18000

Max

18000

Currency

DOP

Per Product

No

High Risk Local
Min

18000

Max

18000

Currency

DOP

Per Product

No

Details
  • Id

    sanitary-registration-simplified-new

    Item

    Registro Sanitario de Productos Sanitarios — procedimiento simplificado, nuevo registro

    Currency

    DOP

    Amount Local

    18000

    Amount Local Formatted

    DOP 18,000

    Frequency

    Per registration

    Notes

    The MSP service listing for the simplified procedure publishes RD$18,000.00 against the line 'Productos Sanitarios' by name, for a new registration; the same figure is published for a renewal. The legal basis cited on that page is Resolución No. 000020.

    Amount Status

    exact-current

    Verification Status

    official-verified

    Source Url

    https://www.msp.gob.do/web?page_id=6279

    Source Title

    MSP — Procedimiento simplificado: costo del servicio por modalidad, línea 'Productos Sanitarios' (base legal: Resolución No. 000020)

    Verified On

    2026-09-16

  • Id

    sanitary-registration-simplified-renewal

    Item

    Registro Sanitario de Productos Sanitarios — procedimiento simplificado, renovación

    Currency

    DOP

    Amount Local

    18000

    Amount Local Formatted

    DOP 18,000

    Frequency

    Per renewal

    Notes

    Same MSP listing, 'Productos Sanitarios' line, renewal modality: RD$18,000.00. Eligibility for the simplified track rests on Resolución No. 000004 of 27 January 2016 and requires a Certificate of Free Sale plus a good-manufacturing-practices certificate from a listed WHO Strict Authority or PAHO/PARF regional reference authority.

    Amount Status

    exact-current

    Verification Status

    official-verified

    Source Url

    https://www.msp.gob.do/web?page_id=6279

    Source Title

    MSP — Procedimiento simplificado: costo del servicio por modalidad, línea 'Productos Sanitarios' (base legal: Resolución No. 000020)

    Verified On

    2026-09-16

  • Id

    advertising-authorisation

    Item

    Autorización de publicidad y promoción (productos sanitarios)

    Currency

    DOP

    Amount Local

    1000

    Amount Local Formatted

    DOP 1,000

    Frequency

    Per brand or product, per authorisation

    Notes

    Advertising and promotion of sanitary products to the general public requires authorisation or notification from DIGEMAPS under the reglamento brought into force by Resolución 000033-15; the published cost is RD$1,000.00 per authorisation and no cost for a publicity notification, with a 25-business-day response time and one fee payment per brand or product.

    Amount Status

    exact-current

    Verification Status

    official-verified

    Source Url

    https://digemaps.gob.do/servicios/autorizacion-notificacion-publicidad-promocion-medicamentos-cosmeticos-productos-sanitarios-higiene-personal-hogar/

    Source Title

    DIGEMAPS — Autorización y notificación de publicidad y promoción de medicamentos, cosméticos, productos sanitarios e higiene (base legal: Resolución 000033-15)

    Verified On

    2026-09-16

Notes
  • Dominican fees are set by product family, not by device risk class, so the low- and high-risk bands carry the same figure. The bands carry the only registration charge that an official source publishes against sanitary products by name: the simplified-procedure fee of RD$18,000.00, for a new registration and for a renewal alike.
  • Every amount published here is an exact figure printed in an official source and named for its product family at row level: the MSP simplified-procedure listing prices sanitary products at RD$18,000.00 by that name, and the DIGEMAPS advertising service page, whose scope covers medicinal, cosmetic, sanitary and personal-hygiene products, prices an authorisation at RD$1,000.00 and a publicity notification at no cost.
  • No amount is published here for the ordinary, non-simplified registration route. Its tariff sits in Resolución 000020, which could not be retrieved (digemaps.gob.do/descargas returns 404 and the wp-json media endpoint returns 401), and the only figure the DIGEMAPS sanitary-products registration and renewal pages print is RD$9,000.00 under the fixed unit label 'Para Medicamento' — a medicine figure on a sanitary-products service page, which cannot be read as the sanitary-products fee and is therefore not published. That is why this record carries three detail rows rather than five.
  • Payment is made by deposit or certified cheque to the Tesorería Nacional account at Banco de Reservas, and the receipt must be no older than three months.
  • A verified zero exists in this schedule: a publicity notification to DIGEMAPS carries no cost, unlike the RD$1,000.00 advertising authorisation.
Last Updated

2026-09-16

Verification Status

official-verified

Official Sources
  • Title

    MSP — Procedimiento simplificado: costo del servicio por modalidad, línea 'Productos Sanitarios' (base legal: Resolución No. 000020)

    Url

    https://www.msp.gob.do/web?page_id=6279

    Accessed Date

    2026-09-16

  • Title

    DIGEMAPS — Autorización y notificación de publicidad y promoción de medicamentos, cosméticos, productos sanitarios e higiene (base legal: Resolución 000033-15)

    Url

    https://digemaps.gob.do/servicios/autorizacion-notificacion-publicidad-promocion-medicamentos-cosmeticos-productos-sanitarios-higiene-personal-hogar/

    Accessed Date

    2026-09-16

Reviewed On

2026-09-16

Amount Status

exact-current

Range Available

Yes

Additional certifications and licences · 1 record
Open Dominican Republic certifications
Slug

dominican-republic

Market

Dominican Republic

Confidence

low

Schemes
  • Id

    dominican-republic-medical-electrical-safety-and-emc

    Name

    Medical electrical safety and EMC evidence inside the sanitary registration

    Category

    Medical Electrical Safety

    Status

    Included In Medical Registration

    Object

    Finished Device

    Note

    The Dominican Republic operates no separate electrical-safety or EMC certificate for medical devices. The DIGEMAPS registration requirement list for sanitary products asks instead for a product description listing the main parts and, where applicable, the qualitative-quantitative composition and specifications; plans or schematics of the product for medical devices; technical studies and analytical checks with a summary of design tests and specifications; and a current good-manufacturing-practices or quality-system certificate of the manufacturing laboratory corresponding to the product's classification. Electrical-safety and EMC evidence therefore enters the dossier as manufacturer documentation inside the sanitary registration, and no national conformity mark or certificate is issued against it.

    Source Urls
    • https://digemaps.gob.do/servicios/registro-sanitario-de-productos-sanitarios/
    Source Binding

    reviewed

  • Id

    cne-radioactive-source-import-permit

    Name

    CNE import permit for radioactive sources and ionizing-radiation-emitting devices

    Category

    Ionizing Radiation

    Status

    Mandatory At Import

    Object

    Radiation Emitting Product

    Note

    The Gerencia de Asuntos Nucleares of the Comisión Nacional de Energía publishes a Permiso de Importación de Fuentes Radiactivas o Dispositivos Emisores de Radiaciones Ionizantes at RD$6,600.00 with a 15-business-day clock. The same page sets out the practice typology that decides which licence a facility needs: type I covers irradiators, linear accelerators, teletherapy Co-60/Cs-137, brachytherapy and I-131; type II covers medical diagnostic X-ray, tomography, mammography and panoramic dental equipment; type III covers periapical dental X-ray, industrial gauges and customs X-ray. CNE states that the applicability of the listed requirements is determined by the Norma de Protección Radiológica. The instrument that mandates the permit (Ley 4189 or the Norma de Protección Radiológica itself) was not retrieved.

    Source Urls
    • https://cne.gob.do/servicios/nuclear/
    Source Binding

    reviewed

  • Id

    cne-practice-operation-licence

    Name

    CNE institutional operating licence and radiological protection officer licence

    Category

    Ionizing Radiation

    Status

    Mandatory For Use Site

    Object

    Radiation Practice Or Use Site

    Note

    A facility that runs a radiation practice needs a Licencia Institucional de Operación — RD$13,200.00 and 25 business days for Práctica Tipo II (medical diagnostic radiology) and RD$6,500.00 for inscription in the type III register (RD$6,600.00 for the periapical dental variant) — and must employ a licensed Encargado de Protección Radiológica; CNE states that where four or more technical staff are involved a licensed EPR is required. Operators need a personal Licencia Personal de Operación (RD$6,600.00 for type I, RD$3,300.00 for types II and III), and a licence for definitive institutional closure costs RD$13,200.00 for type I and RD$6,600.00 for type II. The duty sits on the practice and its personnel, not on the device.

    Source Urls
    • https://cne.gob.do/servicios/nuclear/
    Source Binding

    reviewed

  • Id

    indocal-legal-metrology-model-approval-and-verification

    Name

    INDOCAL legal-metrology model approval, batch examination and verification

    Category

    Legal Metrology

    Status

    Mandatory If Feature

    Object

    Regulated Measuring Instrument

    Note

    Art. 39 of the Ley No. 166-12 (SIDOCAL) makes INDOCAL the national authority responsible for the technical operations of legal or regulatory metrology; Art. 60 gives it the powers of verification and certification of the instruments and equipment used to weigh or measure throughout the national territory and Art. 61 sets out its legal-metrology competence, including the approval of models and the verification that determines whether an instrument's error is within the permitted limits; Art. 110 assigns market inspection in legal metrology to Pro Consumidor, which checks that instruments carry INDOCAL's approval and verification, and Art. 112 makes the sale of unverified instruments a sanctionable breach. INDOCAL's Tarifa de Servicios (Resolución CD-01-2022, adopted 12 July 2022) prices the device-relevant operations: approval of a model of measuring instrument subject to metrological control (RTM-001) at RD$15,000.00, examination of a clinical-thermometer model at RD$27,000.00, batch examination of glass liquid-in-glass clinical thermometers at RD$15.00 per unit up to 500 units (RD$10.00 up to 35,000, RD$7.00 above) and of digital and radiation thermometers at RD$25.00 per unit up to 500 (RD$15.00 up to 35,000, RD$10.00 above), and the sale of a repair seal at RD$450.00. Clinical thermometers are therefore a medical device expressly inside the legal-metrology regime.

    Source Urls
    • https://indocal.gob.do/download/2321/sidocal/66883/ley-no-166-12-ley-sidocal-2.pdf
    • https://indocal.gob.do/download/2047/resoluciones/85198/resolucion-cd-01-2022-2.pdf
    Source Binding

    reviewed

Official Sources
  • Authority

    DIGEMAPS (MSPAS)

    Topic

    registration requirements for sanitary products (medical devices)

    Url

    https://digemaps.gob.do/servicios/registro-sanitario-de-productos-sanitarios/

  • Authority

    CNE — Gerencia de Asuntos Nucleares

    Topic

    nuclear and ionizing-radiation licences and import permits

    Url

    https://cne.gob.do/servicios/nuclear/

  • Authority

    INDOCAL

    Topic

    Ley No. 166-12 (SIDOCAL) — INDOCAL as legal-metrology authority

    Url

    https://indocal.gob.do/download/2321/sidocal/66883/ley-no-166-12-ley-sidocal-2.pdf

  • Authority

    INDOCAL

    Topic

    Tarifa de Servicios, Resolución CD-01-2022 — metrology and conformity-assessment tariffs

    Url

    https://indocal.gob.do/download/2047/resoluciones/85198/resolucion-cd-01-2022-2.pdf

Keep researching this market
View the Dominican Republic resource hub →
DJ Fang
Need to apply Dominican Republic's requirements to a product?
Confirm the current DIGEMAPS pathway, evidence, and local-role details for the actual device before filing.
Pricing